Skip to content
Stop using now Drug recall · FDA · Published August 22, 2017

Pfizer Recalls Hydromorphone HCl Injection Due to Sterility Risk

Pfizer recalls specific lots of Hydromorphone HCl Injection due to lack of sterility assurance. Check your vials for lot number 760853A.

🇺🇸 FDA recall #D-1167-2017DrugPfizer / Hospira ›
Take action

Contact the company

Recalling firmPfizer Inc.235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

What happened, in plain English

Pfizer Inc. is recalling Hydromorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vials because they may not be sterile. The issue stems from a damaged sterilizing filter used for nitrogen during manufacturing. This affects 115,370 vials distributed in the United States and Singapore. Read more at govinfonow.com/recall/41353-pfizer-recalls-hydromorphone-hcl-injection-due-to-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/41353-pfizer-recalls-hydromorphone-hcl-injection-due-to-sterility-risk · Updated October 11, 2026 · FDA enforcement record: FDA #D-1167-2017

Cite this page

“Pfizer Recalls Hydromorphone HCl Injection Due to Sterility Risk.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41353-pfizer-recalls-hydromorphone-hcl-injection-due-to-sterility-risk. Based on FDA recall #D-1167-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1167-2017%22&limit=1).

Why it’s dangerous

The lack of sterility assurance means the injection could contain harmful bacteria or contaminants. Using a non-sterile injectable medication can lead to serious infections or other severe health complications when introduced directly into the body.

Who’s affected

Patients who have been prescribed or received Hydromorphone HCl Injection from Pfizer/Hospira between distribution dates prior to August 22, 2017. Healthcare providers and pharmacies holding this specific stock are also affected.

How to tell if you have this one

Look for single-use vials packaged in cartons of 25. The product is Hydromorphone HCl Injection, USP, 2 mg/mL, 1mL. Check the NDC numbers: 0409-3365-11 (carton) and 0409-3365-01 (vial). The specific lot number to check is 760853A.

  • Brand
    Pfizer / Hospira
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    United States Nationwide (including Puerto Rico) and Singapore
Recall numberProduct, codes & lotsQuantityNDC
D-1167-2017HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial); Lot: 760853A115,370 vials0409-2552-11, 0409-2552-01, 0409-3356-11, 0409-3356-01, 0409-2540-11, 0409-2540-01, 0409-3365-11, 0409-3365-01, 0409-3365-10, 0409-1283-03, 0409-1283-31, 0409-1312-03, 0409-1312-30, 0409-1304-03, 0409-1304-31
D-1168-2017Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04; Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/1898,050 vials0409-3375-14, 0409-3375-04, 0409-1443-14, 0409-1443-04
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any vials matching the recalled lot number due to sterility risks.

  2. Contact your provider

    Reach out to your healthcare provider or pharmacist for guidance on replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “United States Nationwide (including Puerto Rico) and Singapore” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 5.5 years after the firm started it.

1. Firm started the recall: Aug 22, 201712. FDA classified it Class II: Sep 15, 201723. Published in FDA’s Enforcement Report: Sep 27, 201734. FDA terminated the recall: Feb 19, 2023420172023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product sold?

The product was distributed nationwide in the United States (including Puerto Rico) and Singapore.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1167-2017 (August 22, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1167-2017 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA